143 related articles for article (PubMed ID: 6285697)
21. Rapid Clathrin-Mediated Uptake of Recombinant α-Gal-A to Lysosome Activates Autophagy.
Ivanova MM; Dao J; Kasaci N; Adewale B; Fikry J; Goker-Alpan O
Biomolecules; 2020 May; 10(6):. PubMed ID: 32486191
[TBL] [Abstract][Full Text] [Related]
22. Establishment of immortalized Schwann cells from Fabry mice and their low uptake of recombinant alpha-galactosidase.
Kawashima I; Watabe K; Tajima Y; Fukushige T; Kanzaki T; Kanekura T; Sugawara K; Ohyanagi N; Suzuki T; Togawa T; Sakuraba H
J Hum Genet; 2007; 52(12):1018-1025. PubMed ID: 17965825
[TBL] [Abstract][Full Text] [Related]
23. Uptake of lysosomal enzymes by human fibroblasts: lack of uptake of fungal or plant glycosidases in comparison with a mammalian enzyme.
Dooley KC; Applegarth DA
J Inherit Metab Dis; 1980; 3(4):145-7. PubMed ID: 6787335
[TBL] [Abstract][Full Text] [Related]
24. α-Galactosidase delivery using 30Kc19-human serum albumin nanoparticles for effective treatment of Fabry disease.
Lee HJ; Park HH; Sohn Y; Ryu J; Park JH; Rhee WJ; Park TH
Appl Microbiol Biotechnol; 2016 Dec; 100(24):10395-10402. PubMed ID: 27353764
[TBL] [Abstract][Full Text] [Related]
25. Lysosomal enzyme replacement using alpha 2-macroglobulin as a transport vehicle.
Tsuji A; Oda R; Sakiyama K; Nagamune H; Itoh K; Kase R; Sakuraba H; Suzuki Y; Matsuda Y
J Biochem; 1994 May; 115(5):937-44. PubMed ID: 7525546
[TBL] [Abstract][Full Text] [Related]
26. Reduced alpha-Gal A enzyme activity in Fabry fibroblast cells and Fabry mice tissues induced by serum from antibody positive patients with Fabry disease.
Ohashi T; Iizuka S; Ida H; Eto Y
Mol Genet Metab; 2008 Jul; 94(3):313-8. PubMed ID: 18456533
[TBL] [Abstract][Full Text] [Related]
27. Lysosomal alpha-galactosidase in endothelial cell cultures established from a Fabry hemizygous and normal umbilical veins.
Hasholt L; Sørensen SA
Hum Genet; 1986 Jan; 72(1):72-6. PubMed ID: 3002954
[TBL] [Abstract][Full Text] [Related]
28. Properties of the residual alpha-galactosidase activity in the tissues of a Fabry hemizygote.
Rietra PJ; Van den Bergh FA; Tager JM
Clin Chim Acta; 1975 Aug; 62(3):401-13. PubMed ID: 809216
[TBL] [Abstract][Full Text] [Related]
29. Correction in trans for Fabry disease: expression, secretion and uptake of alpha-galactosidase A in patient-derived cells driven by a high-titer recombinant retroviral vector.
Medin JA; Tudor M; Simovitch R; Quirk JM; Jacobson S; Murray GJ; Brady RO
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7917-22. PubMed ID: 8755577
[TBL] [Abstract][Full Text] [Related]
30. Enzyme therapy XVII: metabolic and immunologic evaluation of alpha- galactosidase A replacement in Fabry disease.
Desnick RJ; Dean KJ; Grabowski GA; Bishop DF; Sweeley CC
Birth Defects Orig Artic Ser; 1980; 16(1):393-413. PubMed ID: 6256019
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Human Dermal Fibroblasts in Fabry Disease.
Lakomá J; Donadio V; Liguori R; Caprini M
J Cell Physiol; 2016 Jan; 231(1):192-203. PubMed ID: 26058984
[TBL] [Abstract][Full Text] [Related]
32. Relationship of the multiple forms of human alpha-D-galactosidase and alpha-D-fucosidase in the normal and in Fabry's disease.
Beyer E; Schono N; Kozlova I; Wiederschain G
Biochim Biophys Acta; 1990 May; 1038(3):386-9. PubMed ID: 2160280
[TBL] [Abstract][Full Text] [Related]
33. Fabry's disease: biochemical and histochemical studies on hair roots for carrier detection.
Vermorken AJ; Weterings PJ; Spierenburg GT; vanBennekom CA; Wirtz P; deBruyn CH; Oei TL
Br J Dermatol; 1978 Feb; 98(2):191-6. PubMed ID: 204324
[TBL] [Abstract][Full Text] [Related]
34. Enzymatic and functional correction along with long-term enzyme secretion from transduced bone marrow hematopoietic stem/progenitor and stromal cells derived from patients with Fabry disease.
Takenaka T; Hendrickson CS; Tworek DM; Tudor M; Schiffmann R; Brady RO; Medin JA
Exp Hematol; 1999 Jul; 27(7):1149-59. PubMed ID: 10390190
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a chemically modified plant cell culture expressed human α-Galactosidase-A enzyme for treatment of Fabry disease.
Kizhner T; Azulay Y; Hainrichson M; Tekoah Y; Arvatz G; Shulman A; Ruderfer I; Aviezer D; Shaaltiel Y
Mol Genet Metab; 2015 Feb; 114(2):259-67. PubMed ID: 25155442
[TBL] [Abstract][Full Text] [Related]
36. Detection of Fabry's disease heterozygotes by enzyme analysis in single fibroblasts after cell sorting.
Jongkind JF; Verkerk A; Niermeijer MF
Clin Genet; 1983 Apr; 23(4):261-6. PubMed ID: 6303650
[TBL] [Abstract][Full Text] [Related]
37. Lysosomal enzyme activities among Chinese: leukocyte alpha-galactosidase and beta-galactosidase.
Xu YK; Ng WG
Hum Hered; 1988; 38(2):76-82. PubMed ID: 2837434
[TBL] [Abstract][Full Text] [Related]
38. Molecular interaction of imino sugars with human alpha-galactosidase: Insight into the mechanism of complex formation and pharmacological chaperone action in Fabry disease.
Sugawara K; Tajima Y; Kawashima I; Tsukimura T; Saito S; Ohno K; Iwamoto K; Kobayashi T; Itoh K; Sakuraba H
Mol Genet Metab; 2009 Apr; 96(4):233-8. PubMed ID: 19181556
[TBL] [Abstract][Full Text] [Related]
39. [Substrate specificity of multiple forms of human alpha-D-galactosidase and alpha-D-fucosidase].
Baskaeva EM; Shono NI; Kozlova IK; Vidershaĭn GIa
Biokhimiia; 1989 Mar; 54(3):421-6. PubMed ID: 2546612
[TBL] [Abstract][Full Text] [Related]
40. 4-Phenylbutyrate rescues trafficking incompetent mutant alpha-galactosidase A without restoring its functionality.
Yam GH; Roth J; Zuber C
Biochem Biophys Res Commun; 2007 Aug; 360(2):375-80. PubMed ID: 17592721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
